Alkyl Amines Chemicals Earnings Call Transcripts
Fiscal Year 2026
-
First half FY 2026 saw flat revenue and stable margins amid subdued demand and global pressures. New product launches and anti-dumping duties are expected to support growth from Q4 onwards, while ongoing CapEx and R&D investments position the company for future opportunities.
Fiscal Year 2025
-
Volume grew 13% for the year, but top-line growth was limited to 9% due to pricing pressure and oversupply in base amines. EBITDA margin improved to 21%, with double-digit volume growth expected next year, though price pressure is likely to persist.
-
Volume growth reached 17% year-over-year in Q2 FY25, with stable market share and capacity utilization. Margins remain under pressure due to overcapacity and pricing, but new CapEx and product launches are underway, with a focus on volume growth and operational efficiency.